S.296
An act relating to limiting out-of-pocket expenses for prescription insulin drugs
Sponsors:
Sen. Cheryl Hooker
,
Sen. Rebecca Balint, Sen. Alison Clarkson, Sen. Ruth Hardy, Sen. Deborah Ingram, Sen. Richard McCormack, Sen. Alice Nitka, Sen. Richard Sears
Location: House Committee on Health Care
Last Recorded Action: 3/13/2020 - Referred to the Committee on Health Care
Committee Activity - Meeting Full List
Regular Session 2019-2020
Friday, January 24, 2020
-
Committee(s):
-
Senate Committee on Finance
-
3:00 PM
-
S.296 - An act relating to limiting out-of-pocket expenses for prescription insulin drugs
Walk-through
Jennifer Carbee, Deputy Chief Counsel, Office of Legislative Counsel
Stephen Habbe, Director State Government Affairs, American Diabetes Association
Kevin O'Hara, Williston, Vermont
Thursday, February 6, 2020
-
Committee(s):
-
Senate Committee on Finance
-
3:40 PM
-
S.296 - An act relating to limiting out-of-pocket expenses for prescription insulin drugs
Margaret Laggis, Lobbyist, America's Health Insurance Plans
Sara Teachout, Director, Government, Public and Media Relations, Blue Cross/Blue Shield of Vermont
Michael Fisher, Chief Health Care Advocate, Office of the Health Care Advocate, Vermont Legal Aid
Tuesday, February 11, 2020
-
Committee(s):
-
Senate Committee on Finance
-
4:10 PM
-
S.296 - An act relating to limiting out-of-pocket expenses for prescription insulin drugs
Testimony
Saumya Saini, Vermont Medical Society
Sara Teachout, Director, Government, Public and Media Relations, Blue Cross/Blue Shield of Vermont
Susan Gretkowski, Senior Government Affairs Strategist, MVP Healthcare
Wednesday, February 12, 2020
-
Committee(s):
-
Senate Committee on Finance
-
3:30 PM
-
S.296 - An act relating to limiting out-of-pocket expenses for prescription insulin drugs
Pharmacy Benefits, 340b Pricing, Mark-up and Possible Vote
Nancy Hogue, Director of Pharmacy Services, Department of Vermont Health Access (DVHA)
Brian Murphy, Director of Pharmacy and Vendor Management, Blue Cross Blue Shield of Vermont
Devon Green, Vice President of Government Relations, Vermont Association of Hospitals and Health Systems
Michael Fisher, Chief Health Care Advocate, Office of the Health Care Advocate, Vermont Legal Aid
Friday, February 21, 2020
-
Committee(s):
-
Senate Committee on Finance
-
1:30 PM
-
S.296 - An act relating to limiting out-of-pocket expenses for prescription insulin drugs
Committee Discussion, Mark-up and Possible Vote
Jennifer Carbee, Deputy Chief Counsel, Office of Legislative Counsel
Devon Green, Vice President of Government Relations, Vermont Association of Hospitals and Health Systems
Sara Teachout, Director, Government, Public and Media Relations, Blue Cross/Blue Shield of Vermont
Susan Gretkowski, Senior Government Affairs Strategist, MVP Healthcare
Tuesday, February 25, 2020
-
Committee(s):
-
Senate Committee on Finance
-
4:45 PM
-
S.296 - An act relating to limiting out-of-pocket expenses for prescription insulin drugs
Testimony, Review Draft and Vote
Elia Spates Marquis, Newport
Jennifer Carbee, Deputy Chief Counsel, Office of Legislative Counsel
Tuesday, March 10, 2020
-
Committee(s):
-
Senate Committee on Finance
-
4:35 PM
-
S.296 - An act relating to limiting out-of-pocket expenses for prescription insulin drugs
Sirotkin Amendment